Department of Nursing, Duke University Health System, Duke Heart Center, Department of Nursing, Durham, North Carolina.
Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Catheter Cardiovasc Interv. 2020 Jun 1;95(7):E196-E200. doi: 10.1002/ccd.28403. Epub 2019 Jul 16.
Patient centeredness is an essential component of high-quality care, yet little is known regarding the patient experience during procedures performed in the cardiac catheterization lab.
Available literature focuses on the safe delivery of sedation, but does not address patient-reported satisfaction or comfort. Further delineation of how procedural factors impact the patient experience is needed.
We conducted a retrospective, exploratory analysis of adult cardiac catheterization outpatients (n = 375) receiving physician ordered, nurse administered procedural sedation (benzodiazepine and/or opioids) between April and June, 2017. Data were abstracted from the procedural database, Electronic Health Record, and Press Ganey surveys.
The mean age was 63 (SD 12.2), a majority were male (n = 226; 60%), white (n = 271; 73%), and overweight (mean body mass index = 29, SD 6.8). Patient-reported satisfaction with pain control and perceived staff concern for comfort were >75th percentile (Press Ganey survey), with no difference in preprocedure and postprocedure pain scores (p = .596). Intraprocedural medication dose range and mean frequency were highly variable: midazolam (0.25-5.5 mg; 1.48); fentanyl (12.5-200 mcg; 1.63); and hydromorphone (0.5-2.5 mg; 1.33). Median time interval between administration of initial sedation and local anesthetic was 6 min. Patients with longer intervals had less frequent dosing (p < .001) and less total procedural sedation (p < .001). Sensitivity analysis revealed that trainee/fellow involvement (p = .001), younger age (p = .002), and shorter time intervals (p < .001) were associated with increased frequency and larger total dose.
Waiting to gain vascular access following administration of procedural was associated with less frequent subsequent dosing, lower overall administration, and similar patient satisfaction. Optimizing processes for administering periprocedural sedation may allow for less medication without impacting patient experience.
以患者为中心是高质量医疗的一个重要组成部分,但对于在心脏导管实验室进行的操作过程中患者的体验知之甚少。
现有文献侧重于镇静药物的安全使用,但并未涉及患者报告的满意度或舒适度。需要进一步阐明操作因素如何影响患者体验。
我们对 2017 年 4 月至 6 月期间接受医生开具的、护士实施的程序镇静(苯二氮卓类和/或阿片类药物)的成年心脏导管检查门诊患者(n = 375)进行了回顾性、探索性分析。数据从程序数据库、电子健康记录和 Press Ganey 调查中提取。
患者平均年龄为 63 岁(标准差 12.2),大多数为男性(n = 226;60%),白人(n = 271;73%),超重(平均体重指数 29,标准差 6.8)。患者对疼痛控制和医护人员对舒适度的关注的满意度报告>第 75 百分位数(Press Ganey 调查),术前和术后疼痛评分无差异(p =.596)。术中药物剂量范围和平均频率变化很大:咪达唑仑(0.25-5.5 mg;1.48);芬太尼(12.5-200 mcg;1.63);氢吗啡酮(0.5-2.5 mg;1.33)。初始镇静药物和局部麻醉之间的中位时间间隔为 6 分钟。间隔时间较长的患者,药物剂量较低(p<.001),总镇静药物剂量较低(p<.001)。敏感性分析显示,受训者/研究员参与(p =.001)、年龄较小(p =.002)和间隔时间较短(p<.001)与增加频率和更大总剂量相关。
在给予程序镇静后等待获得血管通路与随后的药物剂量较低、总体管理药物剂量较低和患者满意度相似有关。优化围手术期镇静药物管理的流程可能可以减少药物用量,而不会影响患者体验。